Abstract:Tetrahydropyrido [1,2-a]isoindolone derivatives are potent inhibitors of glycogen synthase kinase 3 beta (GSK3 beta) instead of homologous cyclin-dependent kinase 5 (CDK5). Molecular docking, molecular dynamics simulation, and MM/PBSA energy calculation are utilized to reveal the kinase inhibitors' selective mechanism at the molecular level for improving selectivity. Dynamic cross-correlation map (DCCM) analysis is applied to study the effect of the inhibitor on the interactions between each residue in CDK5 and GSK3 beta. The results of molecular docking indicate that the binding modes of three inhibitors with two kinases are especially similar, and residues in the binding pockets of two kinases are aligned with each other based on the sequence comparing analysis of crystal structures. The analysis of Root Mean Square Deviation (RMSD) with little fluctuation underlies the stability and reliability of systems. Its values of CDK5 (similar to 0.15 nm) are less than GSK3 beta (similar to 0.17 nm), and the inhibitor with higher value holds stronger flexibility and conformational changes of kinases. In terms of energies, the electrostatic and van der Walls energies are the major interactions for differentiating the activity between the same inhibitor and two kinases. And the polar solvation energy plays pivotal role in discriminating the selectivity of kinase inhibitor. The residue decomposition indicates that the residues Glu97 and Thr138 of GSK3 beta are the key residues for differentiating the inhibitor selectivity. On the other hand, in the aspect of inter-residue interaction in one kinase, results indicate that the dynamic correlation of residues is different during the binding process of CDK5 and GSK3 beta with inhibitors. The correlation of Thr138 in the hinge domain of GSK3 beta with that of residues Val135-Gln206 is positive, while the correlation of Gln85 and Cys83 similar to Ala150 in CDK5 is unclear, which is a key factor to distinguish inhibitor selectivity.

Study of the Inhibition of Cyclin-Dependent Kinases with Roscovitine and Indirubin-3′-oxime from Molecular Dynamics Simulations

Binding Mechanism of CDK5 with Roscovitine Derivatives Based on Molecular Dynamics Simulations and MM/PBSA Methods.

Molecular models of cyclin-dependent kinase 4 complexed with indirubin and its analogues

Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations

Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.

3D QSAR for GSK-3β Inhibition by Indirubin Analogues

Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method

Exploring the Selectivity of Tetrahydropyrido[1,2-a]isoindolone Derivatives to GSK3 beta and CDK5 by Computational Methods

Pinpointing top inhibitors for GSK3β from pool of indirubin derivatives using rigorous computational workflow and their validation using molecular dynamics (MD) simulations

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Molecular Principle of the Cyclin-Dependent Kinase Selectivity of 4-(Thiazol-5-yl)-2-(phenylamino) Pyrimidine-5-carbonitrile Derivatives Revealed by Molecular Modeling Studies.

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Crystal Structure of Pyridoxal Kinase in Complex with Roscovitine and Derivatives

Understanding the Selectivity of Inhibitors Toward PI4KIIIα and PI4KIIIβ Based Molecular Modeling

Exploring the Mechanism of Action of Spirooxindoles as a Class of CDK2 Inhibitors: A Structure-based Computational Approach

The Interactions Between Purine-Pyrimidine Derivatives and Cdk2 Based on Molecular Dynamic Simulation

Indirubin-3-Oxime Effectively Prevents 6OHDA-Induced Neurotoxicity in PC12 Cells via Activating MEF2D Through the Inhibition of GSK3β

Elucidating the Selective Mechanism of Drugs Targeting Cyclin-Dependent Kinases with Integrated MetaD-US Simulation

Identification of natural marine compounds as potential inhibitors of CDK2 using molecular docking and molecular dynamics simulation approach